Evidence map›Paper›PMID 24423922›Full record

ArticleBritish journal of cancer2014

The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands.

M J Kilsdonk, B A C van Dijk, R Otter, S Siesling, W H van Harten

Abstract read
In one paragraph

Article in British journal of cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M J Kilsdonk1] Department of Research, Comprehensive Cancer Centre the Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands [2] Department of Health Technology and Services Research, School for Management and Governance, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands.
B A C van Dijk1] Department of Research, Comprehensive Cancer Centre the Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands [2] Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
R OtterDepartment of Research, Comprehensive Cancer Centre the Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands.
S Siesling1] Department of Research, Comprehensive Cancer Centre the Netherlands, Postbus 19079, 3501 DB Utrecht, The Netherlands [2] Department of Health Technology and Services Research, School for Management and Governance, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands.
W H van Harten1] Department of Health Technology and Services Research, School for Management and Governance, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands [2] Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOrganisational external peer review was introduced in 1994 in the Netherlands to improve multidisciplinary cancer care. We examined the clinical impact of this programme on colorectal cancer care.

methodsPatients with primary colorectal cancer were included from 23 participating hospitals and 7 controls. Hospitals from the intervention group were dichotomised by their implementation proportion (IP) of the recommendations from each peer review (high IP vs low IP). Outcome measures were the introduction of new multidisciplinary therapies and survival.

resultsIn total, 45 705 patients were included (1990-2010). Patients from intervention hospitals more frequently received adjuvant chemotherapy for stage III colon cancer. T2-3/M0 rectal cancer patients from hospitals with a high IP had a higher chance of receiving preoperative radiotherapy (OR 1.31, 95% CI 1.11-1.55) compared with the controls and low IP group (OR 0.75, 95% CI 0.63-0.88). There were no differences in the use of preoperative chemoradiation for T4/M0 rectal cancer. Survival was slightly higher in colon cancer patients from intervention hospitals but unrelated to the phase of the programme in which the hospital was at the time of diagnosis.

conclusionsSome positive effects of external peer review on cancer care were found, but the results need to be interpreted cautiously due to the ambiguity of the outcomes and possible confounding factors.

Indexed as

Colorectal NeoplasmsPeer Review, Health CareAgedFemaleHumansMaleMiddle AgedNetherlands

Identifiers

PMID24423922
PMCPMC3929891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.